SS-2, Zwolle and Cadillac scores were significantlyhigher in CIN+ group (all p values
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: It is known that early prediction of the patients who may develop contrast-induced is nephropathy (CIN) and initiate prophylactictreatment to reduce the risk of morbidity-mortality, hospitalization and prolonged length of stay.
📊
Key Findings & Data:In our study, we aimed to comparethe Zwolle, Cadillac and Syntax 2 (SS-2) risk scores that are currently used in the management of and predict mortality in patientswith ST elevation myocardial infarction (STEMI) in terms of predicting CIN development.Material and Methods: We enrolled 1622 patients who were diagnosed as STEMI and underwent primary coronary angiographybetween July 2014 and December 2018. 1381 patients were taken to the final analysis and two groups; CIN - (n=1295) and CIN +(n=86) were formed.
💡
Conclusion & Impact:SS-2, Zwolle and Cadillac scores were significantlyhigher in CIN+ group (all p values
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters
Abstract
Aim: It is known that early prediction of the patients who may develop contrast-induced is nephropathy (CIN) and initiate prophylactictreatment to reduce the risk of morbidity-mortality, hospitalization and prolonged length of stay. In our study, we aimed to comparethe Zwolle, Cadillac and Syntax 2 (SS-2) risk scores that are currently used in the management of and predict mortality in patientswith ST elevation myocardial infarction (STEMI) in terms of predicting CIN development.Material and Methods: We enrolled 1622 patients who were diagnosed as STEMI and underwent primary coronary angiographybetween July 2014 and December 2018. 1381 patients were taken to the final analysis and two groups; CIN - (n=1295) and CIN +(n=86) were formed. Risk scores were compared in terms of CIN prediction.Results: The mean age of the patients was 62±8 years and 72% of them were males. SS-2, Zwolle and Cadillac scores were significantlyhigher in CIN+ group (all p values
🔖
Cite This Article
KALKAN, K. (2022). Comparison of Zwolle, Cadillac and Syntax-2 risk scores in predicting contrast nephropathy development in patients with ST elevation. Annals of Medical Research, Cilt: 26 - Sayı: 7, 1197–1200. https://ajindex.com/articles/446815
Littnerova S, Kala P, Jarkovsky J, et al. GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction. PLoS One 2015;10:e0123215
Liu YH, Liu Y, Tan N, et al. Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention. Int Urol Nephrol 2014;46:417-26
Kul S, Uyarel H, Kucukdagli OT, et al. Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI. Herz 2015;40:109-15
Deek H, Newton P, Sheerin N, et al. Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice. Australian critical care: official journal of the Confederation of Australian Critical Care Nurses 2014;27:166-71
Honicker T, Holt K. Contrast-Induced Acute Kidney Injury: Comparison of Preventative Therapies. Nephrol Nurs J 2016;43:109-16
John M. Contrast-Induced Nephropathy (CIN): current state of the evidence on contrast media and prevention of CIN. AHRQ Comparative Effectiveness Reviews 2016;18
Ando G, Trio O. Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention: The Need for a Unifying Definition. Am J Cardiol 2017;119:169
McDonald RJ, McDonald JS, Newhouse JH, et al. Controversies in Contrast Material-induced Acute Kidney Injury: Closing in on the Truth? Radiology 2015;277:627-32
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018;72:2231-64
Sato A, Hoshi T, Kakefuda Y, et al. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. J Cardiol 2015;66:417- 22
Abellas-Sequeiros RA, Raposeiras-Roubin S, Abu-Assi E, et al. Mehran contrast nephropathy risk score: Is it still useful 10 years later? J Cardiol 2016;67:262-7
Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009;5:50-6
Askin L, Akturk E. Association between SYNTAX II score and electrocardiographic evidence of no-reflow in patients with ST-segment elevation myocardial infarction. Turk Kardiyol Dern Ars 2018;46:455-63
Nerlekar N, Ha FJ, Verma KP, et al. Percutaneous Coronary Intervention Us